Zimmermann Lab

  • Funding Support

    We would like to thank everyone who has provided funding support for our research, including the following foundations and agencies.

  • Show All

    Current Funding Support

    P30 DKL078392 Digestive Health Center (Bezerra) 
    Cincinnati Children's Hospital Medical Center
    "Siglec-8: Target for eosinophilic inflammatory diseases" (Zimmermann)
    Role on center-awarded grant: Principal Investigator (10% effort)
    Period: 06/01/12-05/31/13
    Annual direct cost: $50,000

    AI088559-01 (Zimmermann) 
    NIH / NIAID 
    “Role for acidity and GPR65 in food allergy”
    Role on grant: Principal Investigator (30% effort)
    Period: 03/03/10-02/29/13        
    Annual direct cost: $125,000

    Past Funding Support

    P30 DKL078392 Digestive Health Center (Bezerra) 
    Cincinnati Children's Hospital Medical Center
    "Measurement of tissue pH in experimental eosinophilic esophagitis and food allergy" (Zimmermann)
    Role on center-awarded grant: Principal Investigator (10% effort)
    Period: 06/01/11-05/31/12
    Annual direct cost: $50,000

    AI-167552-N (Zimmermann) 
    Allergic Respiratory Diseases Award
    ALA/AAAAI
    “Mechanisms of airway acidification in asthma”
    Role on grant: Principal Investigator (15% effort)
    Period: 07/01/10 -06/30/12            
    Annual direct cost: $50,000

    AI079251-01A1 (Zimmermann)
    NIH / NIAID
    “Role of acidic environment in eosinophilic inflammation”
    Role on grant: Principal Investigator (40% effort)
    Period: 04/01/09-03/31/11 
    Annual direct cost: $150,000

    President's Grant-in-Aid Award (Zimmermann)
    AAAAI
    “Identification and characterization of the CC chemokine receptor-3 promoter”
    Role on grant: Principal Investigator
    Period: 1999-2000
    Annual direct cost: $20,000

    Fellowship in Pulmonary Research (Zimmermann)
    Parker B. Francis
    "Modulation of CC chemokine receptor-3 expression and function"
    Role on grant: Principal Investigator
    Period: 07/01/99-06/30/02
    Annual direct cost: $40,000

    University Research Council Grant (Zimmermann)
    University of Cincinnati
    "Gene transfer into eosinophils using CCR-3-mediated internalization"
    Role on grant: Principal Investigator
    Period: 06/01/01-05/31/02

    Scientist Development Grant (Zimmermann)
    AHA (National)
    "Regulation of CC chemokine receptor 3 expression"
    Role on grant: Principal Investigator
    Period: 01/01/01-12/31/04
    Annual direct cost: $65,000

    Woman Physician in Allergy Junior Faculty Award (Zimmermann)
    AAAAI / Aventis
    “The role of TDAG8 in allergic airway inflammation”
    Role on grant: Principal Investigator
    Period: 2004-2005
    Annual direct cost: $20,000

    Trustee Grant (Zimmermann)
    Cincinnati Children’s Hospital Medical Center
    “The role of TDAG8 in allergic inflammation” 
    Role on grant: Principal Investigator
    Period: 07/01/04-06/30/06
    Annual direct cost: $50,000

    AMA Foundation Seed Grant (Fulkerson)
    Role on grant: Mentor
    Period: 07/01/06-06/30/07
    Award amount: $2,500

    R01 AI53479-01 (Rothenberg)
    NIH / NIAID
    “The role of arginase in allergic airway inflammation”
    Role on grant: Co-investigator (40% effort)
    Period: 11/01/02-10/31/07
    Annual direct cost: $250,000

    Translational Research Initiative Grant (Zimmermann)
    Cincinnati Children’s Hospital Medical Center
    “Targeting eosinophils by anti-Siglec treatment”
    Role on grant: Principal Investigator (15% effort)
    Period: 07/01/07-06/30/08
    Annual direct cost: $96,459

    Contract with Merck Co.
    “The role of GPR65 / TDAG8 in airway inflammation”
    Role on grant: Co-Principal Investigator (25% effort)
    Period: 2007-2008
    Annual direct cost: $100,000

    #6-FY06-1303 (Zimmermann)
    March of Dimes
    “The role of arginine transport in the development of inflammatory homeostasis in the lung”
    Role on grant: Principal Investigator (10% effort)
    Period: 06/01/06-05/30/09
    Annual direct cost: $80,995

    Dana Foundation (Bochner)
    “Novel genetic and therapeutic approaches focusing on Siglec-8 for the diagnosis and treatment of human idiopathic eosinophilic disorders”
    Role on grant: Co-investigator (25% effort)
    Period: 10/07-09/10
    Annual direct cost: $100,000


 
  • Contact Us

    For more information about the lab, contact Nives Zimmermann at nives.zimmermann@cchmc.org.
  • Digestive Health Center

    Zimmermann is an associate member of Cincinnati Children's Digestive Health Center (DHC), which is focused on bench-to-bedside research in pediatric digestive disease. Her current funding award from the DHC supports her investigation of Siglec-8 as a potential target for eosinophilic inflammatory diseases.
  • Research Opportunities

    research opportunities
    Zimmermann is the director of admissions for the MS track of the Immunobiology Graduate Training Program. She mentors graduate students and postdoctoral fellows, as well as clinical fellows from the Allergy / Immunology Fellowship Program, in basic and translational research.